Publicaciones (297) Publicaciones de MARÍA PILAR ESCRIBANO SUBÍAS

2024

  1. Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot study

    Frontiers in Public Health, Vol. 12

  2. Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic

    Mycoses, Vol. 67, Núm. 1

  3. Comment on the article titled “Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension” published by J. Chan et al

    Journal of Heart and Lung Transplantation

  4. Expert center and balloon pulmonary angioplasty network program in chronic thromboembolic pulmonary hypertension: safety and effectiveness of a pioneering experience

    Revista Espanola de Cardiologia

  5. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution

    Mycoses, Vol. 67, Núm. 3

  6. Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE

    Advances in Therapy, Vol. 41, Núm. 3, pp. 1103-1119

  7. Risk Stratification in Pulmonary Veno-Occlusive Disease

    Archivos de Bronconeumologia

  8. Simplified risk stratification based on cardiopulmonary exercise test: A Spanish two-center experience

    Pulmonary Circulation, Vol. 14, Núm. 1

  9. The importance of data in Pulmonary Arterial Hypertension: from international registries to Machine Learning

    Medicina Clinica

  10. Value of exercise right heart catheterization in the differential diagnosis of chronic thromboembolic pulmonary disease

    Revista Espanola de Cardiologia, Vol. 77, Núm. 2, pp. 158-166

2023

  1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    The European respiratory journal, Vol. 61, Núm. 1

  2. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  3. Amphotericin B, itraconazole, posaconazole, and isavuconazole MICs against clinical Mucorales isolates obtained by visual inspection and spectrophotometric reading according to the EUCAST 9.4 procedure

    Medical mycology, Vol. 61, Núm. 5

  4. Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates

    Clinical Microbiology and Infection, Vol. 29, Núm. 12, pp. 1604.e1-1604.e6

  5. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

    European heart journal, Vol. 44, Núm. 29, pp. 2659-2671

  6. Chronic Whipple's disease, a diagnostic challenge for the cardiologist

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 954-955

  7. Correction: Díaz-García et al. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis. J. Fungi 2022, 8, 1228

    Journal of Fungi

  8. Determination of the ability of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify high-biofilm-producing strains

    Frontiers in Microbiology, Vol. 13

  9. Double lung transplantation in pulmonary arterial hypertension associated with congenital heart disease

    Revista espanola de cardiologia (English ed.), Vol. 76, Núm. 2, pp. 132-134

  10. ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge to therapy

    Kardiologia polska, Vol. 81, Núm. 5, pp. 500-504